Synapse loss and gliosis in the molecular layer of the cerebral cortex in Alzheimer's disease and in frontal lobe degeneration
- PMID: 7583681
- DOI: 10.1006/neur.1995.0021
Synapse loss and gliosis in the molecular layer of the cerebral cortex in Alzheimer's disease and in frontal lobe degeneration
Abstract
Changes in density of synapses and astrocytes in the molecular layer of the frontal and parietal cortex were compared in Alzheimer's disease (AD) and frontal lobe degeneration of non-Alzheimer type (FLD). The investigation was limited to the molecular layer because it is possible in this part of the cortex to measure changes in synapses and astrocytes without contamination by nerve cell body changes. In the frontal pole synapse density declined by 40% in both FLD and AD whereas in the parietal area there was a 50% decrease in synapse density in AD but no significant change in FLD. Number of astrocytes showed an inverse relationship to synapse density. There was a significant increase in astrocytes in the frontal cortex in both FLD and AD but in the parietal cortex such an increase was seen only in AD. These results confirm previous reports of synapse loss in AD and demonstrate a similar loss in FLD in the frontal, but not parietal cortex. The findings underscore the regional pattern changes of FLD, previously shown for other parameters, and its difference from that of AD. We propose that these changes in molecular layer may be representative of the pathology (and the functional deficit) within the underlying cortical layers.
Similar articles
-
Cortical synaptic changes and gliosis in normal aging, Alzheimer's disease and frontal lobe degeneration.Dementia. 1996 May-Jun;7(3):128-34. doi: 10.1159/000106867. Dementia. 1996. PMID: 8740626
-
Synapse density related to cerebral blood flow and symptomatology in frontal lobe degeneration and Alzheimer's disease.Dement Geriatr Cogn Disord. 1999;10 Suppl 1:64-70. doi: 10.1159/000051216. Dement Geriatr Cogn Disord. 1999. PMID: 10436344 Clinical Trial.
-
Frontal lobe degeneration of non-Alzheimer type. IV. White matter changes.Arch Gerontol Geriatr. 1987 Sep;6(3):235-43. doi: 10.1016/0167-4943(87)90024-0. Arch Gerontol Geriatr. 1987. PMID: 3689056
-
Frontal lobe degeneration of non-Alzheimer type. Structural characteristics, diagnostic criteria and relation to other frontotemporal dementias.Acta Neurol Scand Suppl. 1996;168:28-30. Acta Neurol Scand Suppl. 1996. PMID: 8997416 Review.
-
Synaptic pathology of Alzheimer's disease.Ann N Y Acad Sci. 1993 Sep 24;695:59-64. doi: 10.1111/j.1749-6632.1993.tb23028.x. Ann N Y Acad Sci. 1993. PMID: 8239314 Review.
Cited by
-
The role of tau in neurodegeneration.Mol Neurodegener. 2009 Mar 11;4:13. doi: 10.1186/1750-1326-4-13. Mol Neurodegener. 2009. PMID: 19284597 Free PMC article.
-
A clinicopathological approach to the diagnosis of dementia.Nat Rev Neurol. 2017 Aug;13(8):457-476. doi: 10.1038/nrneurol.2017.96. Epub 2017 Jul 14. Nat Rev Neurol. 2017. PMID: 28708131 Free PMC article. Review.
-
A Clinical Guide to Frontotemporal Dementias.Focus (Am Psychiatr Publ). 2016 Oct;14(4):448-464. doi: 10.1176/appi.focus.20160018. Epub 2016 Oct 7. Focus (Am Psychiatr Publ). 2016. PMID: 31975825 Free PMC article.
-
Neuroglia in the inferior olivary nucleus during normal aging and Alzheimer's disease.J Cell Mol Med. 2006 Jan-Mar;10(1):145-56. doi: 10.1111/j.1582-4934.2006.tb00296.x. J Cell Mol Med. 2006. PMID: 16563227 Free PMC article.
-
Microglia in frontotemporal lobar degeneration with progranulin or C9ORF72 mutations.Ann Clin Transl Neurol. 2019 Sep;6(9):1782-1796. doi: 10.1002/acn3.50875. Epub 2019 Aug 25. Ann Clin Transl Neurol. 2019. PMID: 31448566 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical